NCT03896243View on ClinicalTrials.gov

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

CompletedOBSERVATIONAL

Enrollment

102

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 1, 2019

Study Completion Date

February 1, 2019

Conditions

Uterine Artery LigationOvarian Reserve

Interventions

DIAGNOSTIC_TEST

Uterine artery ligation (UAL)

"Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.~They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)"

Trial Locations (1)

34000

Pinar Yalcin Bahat, Istanbul

All Listed Sponsors

lead

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

NCT03896243 - Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation | Biotech Hunter | Biotech Hunter